SHEILA LAMBDIN: Open Payments
NPI 1093717233 · WILLIAMSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 23 payments from 10 companies in 2025. Trend: 2023 $21 · 2024 $539 · 2025 $430
Food & beverage: $385Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Lilly USA, LLC | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Exact Sciences Corporation | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: Kerendia, The Cologuard Plus Collection Kit, Auvelity, VRAYLAR, Ozempic, GIVLAARI, CAPLYTA, HETLIOZ.
Industry payments across KY — which companies pay providers there.
